Dr. Peixuan Guo of UK's Pharmaceutical Sciences will be presenting a seminar entitled, Hexameric AAA+ DNA Translocation Nanomotor of Cell and Virus for Single Molecule Sensing, Single Pore DNA Sequencing, Bioreactors and Specific siRNA Delivery.
Abstract: AAA+ family is a class of motors involved in chromosome segregation, nucleic acid replication, DNA repair, genome recombination, viral DNA packaging, and translocation of cellular components. Many of these motors display hexameric arrangements to facilitate DNA motion triggered by ATP. For 35 years it has been popularly believed that viral DNA packaging motor runs through a five-fold/six fold mismatch rotation mechanism. In 1998, a hexameric RNA ring was discovered in the bacteriophage phi29 DNA packaging motor (Fig. 1) and I proposed that the mechanism of the viral DNA packaging motor is similar to that used by the hexameric DNA tracking AAA+ family (Guo et al., 1998, 2: 149-155). This notion has caused a fervent debate since then concerning whether the RNA and the motor ATPase is a hexamer or a pentamer. Our recent X-ray diffraction of RNA crystals, AFM imaging, and single molecule studies have confirmed that the motor is composed a three-coaxial rings with a hexameric RNA ring, a hexameric ATPase, and a dodecameric motor channel that allows one-way traffic for the movement of dsDNA. A novel and unexpected motor mechanism has also been discovered that is completely different from the five-fold/six-fold mismatch mechanism that has been popular for several decades. We also found that several cellular DNA packaging motors use almost the same mechanism as we discovered in the motor of phi29. My presentation will focus on how to apply the unexpected mechanism of the motor and its novel structural components for RNA nanotechnology, single molecule sensing, single pore DNA sequencing, bioreactors, real-time intracellular RNA monitoring, specific drug loading, and delivery of siRNA, miRNA, ribozyme, aptamer and drugs to cancer and viral infected cells.
Bio: Dr. Peixuan Guo is the William Farish Endowed Chair in Nanobiotechnology and the director of the Nanobiotechnology Center at the University of Kentucky. He also serves as the director of the NCI Cancer Nanotechnology Platform Partnership Program: RNA Nanotechnology for Cancer Therapy.
Faculty Host: Dr. Chris Richards